Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28291978 | 0.95 | TSHR (0.73) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL7645188 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL8192555 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL2813622 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL6380732 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL27312 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL2814083 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL21815678 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL4306353 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A | |
| Sulfuric Acid SCHEMBL8192552 | 0.89 | TSHR (0.80) | TSHRMEN1ALDH1A1KMT2ACA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114069028-B | Preparation method of composite solid electrolyte membrane and all-solid lithium battery | 明志科技大学 | 2024-05-03 | — | — | CN | claimed |
| US-11799170-B2 | Method for fabricating gallium-doped lithium lanthanum zirconate, and all-solid-state battery including the same | MING CHI UNIVERSITY OF TECHNOLOGY (TW) | 2023-10-24 | — | — | US | claimed |
| CN-116315046-A | Method for improving brittleness of LLZO/PEO composite electrolyte membrane and application | 西安交通大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114069028-A | Preparation method of composite solid electrolyte membrane and all-solid-state lithium battery | 明志科技大学 | 2022-02-18 | — | — | CN | claimed |
| US-20220045402-A1 | METHOD FOR THE FABRICATION OF A HYBRID SOLID ELECTROLYTE MEMBRANE, AND AN ALL-SOLID-STATE LITHIUM BATTERY USES THE MEMBRANE | MING CHI UNIVERSITY OF TECHNOLOGY (TW) | 2022-02-10 | — | — | US | claimed |
| CN-112195038-A | Crude oil treating agent and preparation method thereof | 四川润和催化新材料股份有限公司 | 2021-01-08 | — | — | CN | claimed |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | ASCENDIS PHARMA A/S (DK) | 2026-04-07 | — | — | US | disclosed |
| CN-114069028-B | Preparation method of composite solid electrolyte membrane and all-solid lithium battery | 明志科技大学 | 2024-05-03 | — | — | CN | disclosed |
| US-11799170-B2 | Method for fabricating gallium-doped lithium lanthanum zirconate, and all-solid-state battery including the same | MING CHI UNIVERSITY OF TECHNOLOGY (TW) | 2023-10-24 | — | — | US | disclosed |
| CN-116315046-A | Method for improving brittleness of LLZO/PEO composite electrolyte membrane and application | 西安交通大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-114069028-A | Preparation method of composite solid electrolyte membrane and all-solid-state lithium battery | 明志科技大学 | 2022-02-18 | — | — | CN | disclosed |
| US-20220045402-A1 | METHOD FOR THE FABRICATION OF A HYBRID SOLID ELECTROLYTE MEMBRANE, AND AN ALL-SOLID-STATE LITHIUM BATTERY USES THE MEMBRANE | MING CHI UNIVERSITY OF TECHNOLOGY (TW) | 2022-02-10 | — | — | US | disclosed |
| US-20210338834-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2021-11-04 | — | — | US | disclosed |
| US-20210330798-A1 | TREATMENT OF INFECTIONS | ASCENDIS PHARMA A/S (DK) | 2021-10-28 | — | — | US | disclosed |
| EP-3856257-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| EP-3856255-A1 | TREATMENT OF INFECTIONS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| CN-113164616-A | Degradable hyaluronic acid hydrogel | 阿森迪斯药物股份有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-112195038-A | Crude oil treating agent and preparation method thereof | 四川润和催化新材料股份有限公司 | 2021-01-08 | — | — | CN | disclosed |
| WO-2020064844-A1 | TREATMENT OF INFECTIONS | ASCENDIS PHARMA A/S (DK) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020064847-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338834-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | CD44, HPSE, MMP13 | TSHR 1264/4885MEN1 2545/4885ALDH1A1 101/4885 |
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | CD44, H1-0, MMP1 | TSHR 493/4885MEN1 2382/4885ALDH1A1 210/4885 |
| US-20210330798-A1 | TREATMENT OF INFECTIONS | H1-10, PM20D2, ELANE | TSHR 3454/4885MEN1 1654/4885ALDH1A1 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.